A team around Takahiko SATO identified miR-195 and miR-497 to

Sermas Co., a venture based at Chiba University, has developed

A PRESTO-sponsored group around Hiroyuki KUBOTA and Katsuyuki YUI have

A group around Yukio NISHIMURA from the National Institute for

Hidetoshi TERAMOTO et al. at NIAS have used transgenic silkworms

In the first program, a „cancer diagnosis and treatment navigation

This treatment is intended for decompensated cirrhosis patients. About 30

Professor Yoshiki SASAI, Deputy Director of RIKEN CDB in Kobe,

The consortium made up of Takenaka Co., Kajima Co., D.C.

The variety (“Red Priest”) is considered a first example of